Public trial registry of the CCC-Munich

Trial CeTeG Study

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
CeTeG Study
World
Full title
:

Phase III trial of CCNU/ Temozolomide (TMZ) combination therapy vs standard TMZ therapy for newly diagnosed MGMT- methylated glioblastoma patients

World
NCT number
:
World
Responsible organization
:
Neurochirurgie Neurochirurgische Klinik Ismaninger Str. 22 81675 München Germany Tum
Indications
Classification Code Description
- C71.9 Gehirn, nicht näher bezeichnet
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chemo

Participants
Function Prename Surname Organization
World Responsible contact Keine Organisationseinheit angegeben Magnifier